Hasan U - Search Results

1

Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer.

Hirsch I, Caux C, Hasan U, Bendriss-Vermare N, Olive D. Hirsch I, et al. Among authors: hasan u. Trends Immunol. 2010 Oct;31(10):391-7. doi: 10.1016/j.it.2010.07.004. Epub 2010 Sep 9. Trends Immunol. 2010. PMID: 20832362 Review.

2

Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH.

de Bouteiller O, Merck E, Hasan UA, Hubac S, Benguigui B, Trinchieri G, Bates EE, Caux C. de Bouteiller O, et al. J Biol Chem. 2005 Nov 18;280(46):38133-45. doi: 10.1074/jbc.M507163200. Epub 2005 Sep 6. J Biol Chem. 2005. PMID: 16144834 Free article.

3

Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs.

Hasan UA, Caux C, Perrot I, Doffin AC, Menetrier-Caux C, Trinchieri G, Tommasino M, Vlach J. Hasan UA, et al. Proc Natl Acad Sci U S A. 2007 May 8;104(19):8047-52. doi: 10.1073/pnas.0700664104. Epub 2007 Apr 26. Proc Natl Acad Sci U S A. 2007. PMID: 17463087 Free PMC article.

4

Targeting pattern recognition receptors in cancer immunotherapy.

Goutagny N, Estornes Y, Hasan U, Lebecque S, Caux C. Goutagny N, et al. Among authors: hasan u. Target Oncol. 2012 Mar;7(1):29-54. doi: 10.1007/s11523-012-0213-1. Epub 2012 Mar 8. Target Oncol. 2012. PMID: 22399234 Review.

5

TLR9 transcriptional regulation in response to double-stranded DNA viruses.

Zannetti C, Parroche P, Panaye M, Roblot G, Gruffat H, Manet E, Debaud AL, Plumas J, Vey N, Caux C, Bendriss-Vermare N, Hasan UA. Zannetti C, et al. J Immunol. 2014 Oct 1;193(7):3398-408. doi: 10.4049/jimmunol.1400249. Epub 2014 Sep 5. J Immunol. 2014. PMID: 25194054

6

TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expression.

Parroche P, Roblot G, Le Calvez-Kelm F, Tout I, Marotel M, Malfroy M, Durand G, McKay J, Ainouze M, Carreira C, Allatif O, Traverse-Glehen A, Mendiola M, Pozo-Kreilinger JJ, Caux C, Tommasino M, Goutagny N, Hasan UA. Parroche P, et al. Among authors: hasan ua. Oncogenesis. 2016 Jul 25;5(7):e244. doi: 10.1038/oncsis.2016.49. Oncogenesis. 2016. PMID: 27454079 Free PMC article.

7

Hepatitis B Virus Blocks the CRE/CREB Complex and Prevents TLR9 Transcription and Function in Human B Cells.

Tout I, Gomes M, Ainouze M, Marotel M, Pecoul T, Durantel D, Vaccarella S, Dubois B, Loustaud-Ratti V, Walzer T, Alain S, Chemin I, Hasan U. Tout I, et al. Among authors: hasan u. J Immunol. 2018 Oct 15;201(8):2331-2344. doi: 10.4049/jimmunol.1701726. Epub 2018 Sep 5. J Immunol. 2018. PMID: 30185518

8

Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88.

Hasan U, Chaffois C, Gaillard C, Saulnier V, Merck E, Tancredi S, Guiet C, Brière F, Vlach J, Lebecque S, Trinchieri G, Bates EE. Hasan U, et al. J Immunol. 2005 Mar 1;174(5):2942-50. doi: 10.4049/jimmunol.174.5.2942. J Immunol. 2005. PMID: 15728506

9

TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.

Hasan UA, Bates E, Takeshita F, Biliato A, Accardi R, Bouvard V, Mansour M, Vincent I, Gissmann L, Iftner T, Sideri M, Stubenrauch F, Tommasino M. Hasan UA, et al. J Immunol. 2007 Mar 1;178(5):3186-97. doi: 10.4049/jimmunol.178.5.3186. J Immunol. 2007. PMID: 17312167

10

EBV latent membrane protein 1 is a negative regulator of TLR9.

Fathallah I, Parroche P, Gruffat H, Zannetti C, Johansson H, Yue J, Manet E, Tommasino M, Sylla BS, Hasan UA. Fathallah I, et al. J Immunol. 2010 Dec 1;185(11):6439-47. doi: 10.4049/jimmunol.0903459. Epub 2010 Oct 27. J Immunol. 2010. PMID: 20980631

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page